Chemed (CHE) Equity Average (2010 - 2026)

Chemed has reported Equity Average for 17 years, with the latest figure at $913.7 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 20.57% year-over-year to $913.7 million; the trailing twelve-month figure through Mar 2026 stood at $913.7 million (down 20.57% YoY), and the FY2025 full-year result was $1.0 billion, down 5.77% from the prior year.
• Equity Average for Q1 2026 stood at $913.7 million, down from $1.0 billion in the prior quarter.
• The five-year high for Equity Average was $1.2 billion in Q3 2024, with the low at $645.0 million in Q1 2022.
• Average Equity Average over 5 years is $985.2 million, with a median of $1.0 billion recorded in 2025.
• Year-over-year, Equity Average dropped 29.51% in 2022 and soared 40.17% in 2023.
• Tracing CHE's Equity Average over 5 years: stood at $760.1 million in 2022, then surged by 39.93% to $1.1 billion in 2023, then grew by 10.7% to $1.2 billion in 2024, then declined by 12.68% to $1.0 billion in 2025, then decreased by 11.12% to $913.7 million in 2026.
• The last three Equity Average figures came in at $913.7 million (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison